WARMINSTER, Pa. (AP) _ Arbutus Biopharma Corp. (ABUS) on Wednesday reported a loss of $16.4 million in its first quarter.

The Warminster, Pennsylvania-based company said it had a loss of 21 cents per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 22 cents per share.

The biopharmaceutical company posted revenue of $2.1 million in the period, which did not meet Street forecasts. Five analysts surveyed by Zacks expected $3.9 million.

The company’s shares closed at $3.33. A year ago, they were trading at $1.21.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ABUS at https://www.zacks.com/ap/ABUS